We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Metastatic Breast Cancer
Center of Excellence
Interested in receiving weekly updates about the Metastatic Breast Cancer Center of Excellence?
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
KANNAN VENKATESAN
May 09, 2018
Ca. left Breast, pT1b N1a
The treatment Plan for such a patient in our department:
Breast +Axillary RT., with or without SCF RT as given below
Her age is >50, T1lesion, ER positive, G-1tumour. If there is no LVI, RT plan will be Whole breast Rt including level I & II axilla. Contour will be done for Level I & II axilla which will be included in the Breast field as modified tangents. Dose will be 42.7Gy/16Fr followed by supplement RT to breast tumour bed-10Gy/5Fr.
RT will be delivered by deep inspiratory breath hold method, 4D-RT, to reduce the cardiac dose
If LVI is present, then add additional field to cover axilla level-III with SCF to a dose 45Gy/20Fr
Even if Oncotype DX score is low, the plan will be the same because of N1a status
Luca Licata
May 11, 2018
Considering the low tumor burden (T1b and only one positive lymph node) and its biologic characteristics (G1, ER/PR +), I probably would not propose the use of post-mastectomy RT. I would prescribe only adjuvant endocrine therapy
Dec 23, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
KANNAN VENKATESAN
May 09, 2018
Luca Licata
May 11, 2018
Dec 23, 2024
Pending Moderator approval.